Fidaxomicin: a new macrocyclic, RNA polymerase-inhibiting antibiotic for the treatment ofClostridium difficileinfections

Changes in laboratory and clinical workload for Clostridium difficile infection from 2003 to 2007 in hospitals in Edinburgh

(2010) S. Reddy et al.   CLINICAL MICROBIOLOGY AND INFECTION

The fascination with probiotics for Clostridium difficile infection: Lack of evidence for prophylactic or therapeutic efficacy

(2009) Mark Miller   ANAEROBE

Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection

(2009) D.M. Citron et al.   ANAEROBE

Nitazoxanide versus Vancomycin inClostridium difficileInfection: A Randomized, Double‐Blind Study

(2009) Daniel M. Musher et al.   CLINICAL INFECTIOUS DISEASES

Health Care–AssociatedClostridium difficileInfection in Adults Admitted to Acute Care Hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program Study

(2009) Denise Gravel et al.   CLINICAL INFECTIOUS DISEASES

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)

(2009) M.P. Bauer et al.   CLINICAL MICROBIOLOGY AND INFECTION

Clostridium difficile: controversies and approaches to management

(2009) Martijn P Bauer et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 Strain

(2009) Jennifer R. O'Connor et al.   GASTROENTEROLOGY

New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration

(2009) Michelle M. Merrigan et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Recurrent Clostridium difficile infection: causality and therapeutic approaches

(2009) Stuart Johnson   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Historical and changing epidemiology of healthcare-associated infections

(2009) A. Pearson   JOURNAL OF HOSPITAL INFECTION

Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series

(2009) A.A. MacConnachie et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Clostridium diffcile associated infection, diarrhea andcolitis

(2009) Perry Hookman et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Safety, Tolerance, and Pharmacokinetic Studies of OPT-80 in Healthy Volunteers following Single and Multiple Oral Doses

(2008) Y. K. Shue et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Outcomes, Safety, and Pharmacokinetics of OPT-80 in a Phase 2 Trial with Patients with Clostridium difficile Infection

(2008) T. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection

(2008) T. J. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Historical Perspectives on Studies ofClostridium difficileandC. difficileInfection

(2008) John G. Bartlett   CLINICAL INFECTIOUS DISEASES

Skin and Environmental Contamination With Vancomycin-Resistant Enterococci in Patients Receiving Oral Metronidazole or Oral Vancomycin Treatment for Clostridium difficile–Associated Disease

(2008) Ajay K. Sethi et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY